Page 37 - 《中国药房》2024年13期
P. 37

本研究通过代谢途径富集分析和文献调研发现,主                         [ 6 ]  LIU W X,JIA F L,HE Y Y,et al. Protective effects of 5-
          要是嘧啶代谢、丁酸盐代谢、脂肪酸合成、酪氨酸代谢、                               methoxypsoralen  against  acetaminophen-induced  hepato‐
          β-丙氨酸代谢、烟酸和烟酰胺代谢、半胱氨酸和蛋氨酸                               toxicity in mice[J]. World J Gastroenterol,2012,18(18):
          代谢以及谷胱甘肽代谢等代谢途径在肝纤维化小鼠中                                 2197-2202.
          发生了显著变化。相关研究发现,肝脏嘧啶在高脂合并                           [ 7 ]  SCHOLTEN  D,TREBICKA  J,LIEDTKE  C,et  al.  The
                                                                  carbon tetrachloride model in mice[J]. Lab Anim,2015,49
          胆碱缺乏饮食、高脂高胆固醇高果糖饮食分别诱导的 2
                                                                 (Suppl. 1):4-11.
          种肝纤维化小鼠模型中维持较低水平,而抑制嘧啶分解                           [ 8 ]  KOWALCZYK  J, KURACH  Ł, BOGUSZEWSKA-
                                   [14]
          代谢可以有效改善肝纤维化 。丁酸可经门静脉进入
                                                                  CZUBARA  A,et  al.  Bergapten  improves  scopolamine-
          肝脏下调脂质合成基因的表达,改善非酒精性脂肪性肝                                induced memory impairment in mice via cholinergic and
          病所致的肝损伤;此外,在肠道中,丁酸可经革兰氏阳性                               antioxidative mechanisms[J]. Front Neurosci,2020,14:730.
          菌厚壁菌属分解代谢成丁酸盐的形式,而丁酸盐作为一                           [ 9 ]  WANG L C,SU B Z,ZENG Z D,et al. Ion-pair selection
          种有益的短链脂肪酸,可以改善高脂饮食诱导的肥胖和                                method  for  pseudotargeted  metabolomics  based  on
          抑制非经典的转化生长因子β通路,进而改善小鼠肝纤                                SWATH MS acquisition and its application in differential
          维化症状    [15―16] 。此外,谷胱甘肽代谢途径对于肝纤维化                      metabolite  discovery  of  type  2  diabetes[J]. Anal  Chem,
                            [17]
          的防治具有重要意义 。谷胱甘肽由谷氨酸、半胱氨酸                                2018,90(19):11401-11408.
          和甘氨酸结合而成,是一种有效的抗氧化剂和自由基清                           [10]  HONG Y Z,SHEN M Y,YU Q,et al. UPLC-Q-TOF/MS-
                                                                  based metabolomics reveals modulatory effects of Mesona
          除剂,谷胱甘肽的缺失会引起肝细胞氧化和抗氧化系统                                chinensis  Benth  polysaccharide  in  liver  injury  mice  in‐
          失衡,进而引起谷胱甘肽过氧化物酶4的失活,导致肝细
                                                                  duced by cyclophosphamide[J]. Food Sci Hum Wellness,
                                          [18]
          胞发生铁死亡,促进肝纤维化的发展 。本研究发现,                                2023,12(2):584-595.
          血清中还原型谷胱甘肽和半胱氨酸水平在BP干预后显                           [11]  HE  S,LUO Y  R,MA W  G,et  al.  Endothelial  POFUT1
          著升高,提示 BP 可能通过促进还原型谷胱甘肽的合成                              controls injury-induced liver fibrosis by repressing fibrinogen
          产生抗氧化作用,进而减少肝细胞铁死亡,改善肝纤                                 synthesis[J]. J Hepatol,2024:S0168-S8278(24)00152-1.
          维化。                                                [12]  RHO H,TERRY A R,CHRONIS C,et al. Hexokinase 2-
              综上所述,BP 可能通过调节肝纤维化小鼠血清中                             mediated  gene  expression  via  histone  lactylation  is  re‐
          嘧啶代谢、丁酸盐代谢和谷胱甘肽代谢途径等达到治疗                                quired for hepatic stellate cell activation and liver fibrosis
          肝纤维化的作用。后续,本课题组将设计体内外实验进                                [J]. Cell Metab,2023,35(8):1406-1423.e8.
          一步研究BP抗肝纤维化的具体分子机制,从而为BP在                          [13]  ZHAO Z H,XIN F Z,XUE Y Q,et al. Indole-3-propionic
          肝纤维化临床治疗中的应用提供更多依据。                                     acid  inhibits  gut  dysbiosis  and  endotoxin  leakage  to
                                                                  attenuate steatohepatitis in rats[J]. Exp Mol Med,2019,51
          参考文献                                                   (9):1-14.
          [ 1 ]  KISSELEVA  T,BRENNER  D.  Molecular  and  cellular
                                                             [14]  LUUKKONEN P K,SAKUMA I,GASPAR R C,et al. In‐
              mechanisms of liver fibrosis and its regression[J]. Nat Rev   hibition of HSD17B13 protects against liver fibrosis by in‐
              Gastroenterol Hepatol,2021,18(3):151-166.           hibition  of  pyrimidine  catabolism  in  nonalcoholic  steato‐
          [ 2 ]  陆伦根,尤红,谢渭芬,等 . 肝纤维化诊断及治疗共识:
                                                                  hepatitis[J].  Proc  Natl Acad  Sci  U  S A,2023,120(4):
              2019年[J].临床肝胆病杂志,2019,35(10):2163-2172.             e2217543120.
              LU L G,YOU H,XIE W F,et al.Consensus on the diag-   [15]  ZHAO Z H,WANG Z X,ZHOU D,et al. Sodium buty-
              nosis and therapy of hepatic fibrosis:2019[J]. J Clin Hepa‐  rate supplementation inhibits hepatic steatosis by stimula-
              tol,2019,35(10):2163-2172.                          ting liver kinase B1 and insulin-induced gene[J]. Cell Mol
          [ 3 ]  史俊豪,丘琴,刘晓芳,等. 佛手化学成分和药理作用及                       Gastroenterol Hepatol,2021,12(3):857-871.
              其质量标志物(Q-Marker)预测分析[J]. 中华中医药学                [16]  GART  E,VAN  DUYVENVOORDE  W,TOET  K,et  al.
              刊,2023,41(4):17-28.                                 Butyrate  protects  against  diet-induced  NASH  and  liver
              SHI  J  H,QIU  Q,LIU  X  F,et  al.  Chemical  components   fibrosis and suppresses specific non-canonical TGF-β sig‐
              and pharmacological action for Foshou(Citri Sarcodacty‐  naling  pathways  in  human  hepatic  stellate  cells[J].  Bio‐
              lis Fructus) and predictive analysis on Q-marker[J]. Chin   medicines,2021,9(12):1954.
              Arch Tradit Chin Med,2023,41(4):17-28.         [17]  KONG  Z Y,LIU  R,CHENG Y  R. Artesunate  alleviates
          [ 4 ]  LUO  T,JIA  X,FENG  W  D,et  al.  Bergapten  inhibits   liver  fibrosis  by  regulating  ferroptosis  signaling  pathway
              NLRP3 inflammasome activation and pyroptosis via pro‐  [J]. Biomed Pharmacother,2019,109:2043-2053.
              moting mitophagy[J]. Acta Pharmacol Sin,2023,44(9):  [18]  FU Y D,ZHOU X X,WANG L,et al. Salvianolic acid B
              1867-1878.                                          attenuates liver fibrosis by targeting Ecm1 and inhibiting
          [ 5 ]  ADAKUDUGU  E A,AMEYAW  E  O,OBESE  E,et  al.     hepatocyte ferroptosis[J]. Redox Biol,2024,69:103029.
              Protective effect of bergapten in acetic acid-induced coli‐   (收稿日期:2024-02-27  修回日期:2024-06-03)
              tis in rats[J]. Heliyon,2020,6(8):e04710.                                           (编辑:林 静)



          中国药房  2024年第35卷第13期                                              China Pharmacy  2024 Vol. 35  No. 13    · 1575 ·
   32   33   34   35   36   37   38   39   40   41   42